VANCOUVER, Washington, May 28, 2024 CytoDyn Inc. , a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that.
CytoDyn Announces Webcast to Provide Company Update tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.